pI: 5.2114 |
Length (AA): 249 |
MW (Da): 27343 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
11 | 242 | 1ex2 (A) | 2 | 185 | 36.00 | 0 | 1 | 1.06 | -0.26 |
12 | 232 | 1ex2 (A) | 3 | 175 | 42.00 | 0 | 1 | 1.07 | 0.59 |
9 | 244 | 2p5x (A) | 10 | 213 | 42.00 | 0 | 1 | 1.29279 | -0.11 |
91 | 135 | 4xwu (A) | 68 | 111 | 45.00 | 0.88 | 0.92 | 0.637723 | 0.59 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127554)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_III007990 | Maf-like protein family protein |
Brugia malayi | Bm1_26810 | maf protein |
Candida albicans | CaO19.7051 | similar to S. cerevisiae YOR111W |
Candida albicans | CaO19_7051 | hypothetical protein |
Caenorhabditis elegans | CELE_C54G4.6 | Protein DOD-18 |
Chlamydia trachomatis | CT_349 | Maf protein |
Dictyostelium discoideum | DDB_G0267852 | hypothetical protein |
Drosophila melanogaster | Dmel_CG9515 | CG9515 gene product from transcript CG9515-RB |
Escherichia coli | b3248 | Maf-like protein |
Echinococcus granulosus | EgrG_001023400 | maf protein |
Echinococcus granulosus | EgrG_001023500 | maf protein |
Entamoeba histolytica | EHI_146200 | septum formation protein maf, putative |
Echinococcus multilocularis | EmuJ_001023500 | maf protein |
Echinococcus multilocularis | EmuJ_001023400 | maf protein |
Giardia lamblia | GL50803_13889 | Maf-like protein yhdE |
Homo sapiens | ENSG00000169093 | acetylserotonin O-methyltransferase-like |
Loa Loa (eye worm) | LOAG_04181 | hypothetical protein |
Mycobacterium leprae | ML0729c | Conserved hypothetical protein |
Mus musculus | 69099 | RIKEN cDNA 1810009N02 gene |
Mycobacterium tuberculosis | Rv3282 | Conserved hypothetical protein |
Mycobacterium ulcerans | MUL_2634 | Maf-like protein |
Neospora caninum | NCLIV_011970 | septum formation protein maf, putative |
Oryza sativa | 4333958 | Os03g0724700 |
Onchocerca volvulus | OVOC13398 |
|
Plasmodium berghei | PBANKA_1412100 | Maf-like protein, putative |
Plasmodium falciparum | PF3D7_1313700 | Maf-like protein, putative |
Plasmodium knowlesi | PKNH_1414300 | Maf-like protein, putative |
Plasmodium vivax | PVX_122505 | septum formation protein Maf domain containing protein |
Plasmodium yoelii | PY02834 | maf protein |
Saccharomyces cerevisiae | YOR111W | hypothetical protein |
Schistosoma japonicum | Sjp_0103960 | ko:K06287 septum formation protein, putative |
Schistosoma mansoni | Smp_061040 | maf protein |
Schmidtea mediterranea | mk4.000952.00 | |
Trypanosoma brucei gambiense | Tbg972.1.2030 | septum formation protein MAF homologue, putative |
Trypanosoma brucei | Tb927.1.3280 | septum formation protein MAF homologue, putative |
Trypanosoma congolense | TcIL3000_0_45370 | septum formation protein MAF homologue, putative |
Trypanosoma cruzi | TcCLB.509819.30 | septum formation inhibitor, Maf-like protein, putative |
Trypanosoma cruzi | TcCLB.503663.10 | septum formation inhibitor, Maf-like protein, putative |
Toxoplasma gondii | TGME49_301430 | septum formation protein maf, putative |
Theileria parva | TP04_0705 | septum formation protein MAF, putative |
Trichomonas vaginalis | TVAG_160900 | O-methyltransferase, putative |
Trichomonas vaginalis | TVAG_265960 | O-methyltransferase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0192 | Maf-like protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3341 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.1.3280 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.3280 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.3280 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.1.3280 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3248 | Escherichia coli | non-essential | goodall |
TGME49_301430 | Toxoplasma gondii | Probably non-essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.